Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) EBITDA (2016 - 2025)

Milestone Scientific (MLSS) has disclosed EBITDA for 16 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 47.13% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.7 million through Dec 2025, up 16.09% year-over-year, with the annual reading at -$5.7 million for FY2025, 15.69% up from the prior year.
  • EBITDA hit -$1.1 million in Q4 2025 for Milestone Scientific, up from -$1.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$984373.0 in Q1 2021 to a low of -$2.9 million in Q2 2022.
  • Historically, EBITDA has averaged -$1.8 million across 5 years, with a median of -$1.8 million in 2022.
  • Biggest five-year swings in EBITDA: plummeted 93.02% in 2022 and later surged 47.13% in 2025.
  • Year by year, EBITDA stood at -$1.6 million in 2021, then fell by 27.21% to -$2.0 million in 2022, then increased by 0.71% to -$2.0 million in 2023, then decreased by 3.51% to -$2.0 million in 2024, then soared by 47.13% to -$1.1 million in 2025.
  • Business Quant data shows EBITDA for MLSS at -$1.1 million in Q4 2025, -$1.1 million in Q3 2025, and -$1.5 million in Q2 2025.